Dabrafenib/Trametinib/Hydroxychloroquine for Advanced Pretreated BRAF V600 Mutant Melanoma
Clinical trial NCT03754179 · UNKNOWN
Trial details
- NCT number
- NCT03754179
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-23
- Primary completion
- 2021-12-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.